Every round on record, with the sources behind each and the investors on them.
A telehealth platform that delivers insurance-covered care for women with hormonal, metabolic, and reproductive conditions
allarahealth.comNew YorkHealthtech
5 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Sources agree on the $30M round, its $75M total funding figure, and the five named investors; no source identifies a lead investor, valuation, or headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $30M $75M to date | 2026-10-12 | not stated | 4 outlets. #42 in Trending |
5 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 5 sources
Sources agree on the $30M round, its $75M total funding figure, and the five named investors; no source identifies a lead investor, valuation, or headquarters. | ||||
Allara provides insurance-covered virtual care that pairs women with medical providers and registered dietitians to treat hormonal, metabolic, and reproductive or gynecological conditions.
Allara says women with conditions such as PCOS, endometriosis, and thyroid disorders often face fragmented or dismissive care; in its latest survey, 58% of more than 1,600 women had already seen at least two providers and 80% of those who had seen another provider said their symptoms were dismissed or minimized. The latest $30 million funding brings total funding to $75 million and is intended to extend AI-enabled care, insurance and other partnerships, and women's-health research as Allara builds on more than 120,000 women served.
Checked against 15 sources today
Also named as backers in company research: Global Founders Capital, Great Oaks Venture Capital, Humbition, Vanterra, Gaingels, Tom Lee, Maggie Sellers